Article • Digital Pathology
Deep Blue meets Hematoxilin and Eosin
In the nineties Deep Blue, the famous chess computer, defeated Kasparow. Only a year ago Google’s Deepmind managed to master the ancient Chinese Go, known for its utmost complexity.
Personalised medicine
News • Gene-based testing
Skewing the aim of targeted cancer therapies
Headlines, of late, have touted the successes of targeted gene-based cancer therapies, such as immunotherapies, but, unfortunately, also their failures.
News • Pediatric leukemia
‘Turbocharged Artificial Intelligence’ could personalize combination therapy
A team of UCLA bioengineers has demonstrated that its technology may go a long way toward overcoming the challenges of treatment for acute lymphoblastic leukemia, among the most common types of cancer in children, and has the potential to help doctors personalize drug doses.
Article • Pathology
Creating a data powerhouse
The ability to digitise results from patient samples has been one of the key enabling technologies that make personalised medicine possible now, says Dr Fiona Carragher, the Deputy Chief Scientific Officer for NHS England.
Article • Personalised medicine
Many issues must be resolved
Hardly any topic has been discussed as broadly as personalised medicine, with countless stakeholders, ministries and organisations involved. That’s good news says Professor Angela Brand, Professorial Fellow at the Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT) and Professor at the Department of Health, Medicine and Life Sciences at Maastricht University.…
Article • Denmark
Successful digital pathology
Advanced computer software underpins a service - coupled with a countrywide database, which enables Denmark’s pathologists to optimise the assessment of patients’ specimens.In turn, the digitisation of the system in recent years has led to significant improvements in pathology services, delivering greater efficiency and advances in patient safety.
Interview • Personalized medicine
“We have to establish a digital health network”
Healthcare and business professionals as well as scientists consider Big Data a promising technology to advance medical research and patient care. “Big Data analysis allows us to better tailor therapies based on the individual patient’s status, that is to implement personalized healthcare,” says Dominik Bertram, Development Manager at SAP and Head of the development field “Personalized…
Sponsored • Fat data
The Digital Path (ology) to Personalized Medicine
Though it is the underlying science that drives diagnosis and treatment decisions, pathology is an often overlooked field. As part of the health continuum, as the turning point for treatment, as a new source for research and discovery – in all these ways, the power of pathology has gone unnoticed. However, the industry is slowly coming to realize its potential in transforming care, knows Hans…
News • Proteomics
The future of precision medicine
As medical professionals search for new ways to personalize diagnosis and treatment of disease, RPB-supported researchers at the University of Iowa have already put into practice what may be the next big step in precision medicine: personalized proteomics.
Article • Precision imaging
Myth or reality? Focusing on personalised radiology
With precision imaging playing a greater role in daily radiology practice as patients receive ever more personalised care, the detail and extent of that shift is outlined in the ECR session ‘Personalised radiology: myth or reality?’, which includes a presentation from renowned radiologist Professor Gabriel Krestin, chairman of the radiology and nuclear medicine department at Erasmus MC,…
News • Nuclear medicine
Eckert & Ziegler expands cooperation program with drug developers
Eckert & Ziegler AG, a specialist for isotope-based applications in medicine, science and industry, is expanding its cooperation program with promising drug developers in the field of nuclear medicine and will support Curasight, a spin-off based on research by the group of Professor Andreas Kjaer at the National University Hospital (Rigshospitalet) and University of Copenhagen, in obtaining…
News • Epigenomic Analysis
New technology helps personalized medicine
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer, is reported in the research journal Nature Methods.
First full genome of a living organism assembled
Researchers in Canada and the U.K. have for the first time sequenced and assembled de novo the full genome of a living organism, the bacteria Escherichia Coli, using Oxford Nanopore's MinIONTM device, a genome sequencer that can fit in the palm of your hand.
Article • Personalised medicine
Computerised tailor-made retinopathy therapy
Nowadays the concept of personalised medicine is usually applied to oncology. However, there are other clinical disciplines in which therapies tailored to the individual patient are within reach, viz. ophthalmology. In the researchers’ limelight is intravitreal drug delivery since the outcomes of injections into the vitreous differ from patient to patient. Ophthalmologists in Vienna, Austria,…
Article • Telehealth study
England’s Florence looks like a winner
Given the increasing focus on telehealth and telecare services aimed at improving long-term patients’ living conditions and save costs, numerous pilots in various countries have been conducted for proof of concept purposes. Among these, the United Kingdom’s ‘Whole System Demonstrator’ (WSD) programme is the largest randomised controlled trial. Set up by the English National Health Service…
Article • Breast Cancer
Decision-making based on personalized data
No alcohol, but exercise and a healthy diet – that’s what women can do to help prevent breast cancer recommends Prof. Thomas Helbich (Director of Molecular and Gender Imaging at the Medical University of Vienna) who hosted the European Institute for Biomedical Imaging Research (EIBIR) session ‘The complexity of personalized breast care’ at ECR 2015. Report: Chrissanthi Nikolakudi
Article • Infection Control
Periprosthetic infections: a new disease
Early diagnosis and effective therapy of periprosthetic joint infections (PJI) remain a challenge for many physicians due to the complexity and heterogeneity of clinical symptoms. As individual solutions are needed, opportunities to discuss and exchange ideas are welcome, as clearly shown during the satellite symposium on the diagnosis and treatment of periprosthetic knee infections held at this…
Article • Interview
Multidisciplinarity is the key for gastroenterologists
At the close of the Gastrointestinal Medicine and Surgery meeting in Leipzig, Professor Peter R Galle, Congress President of the German Society for Gastroenterology, Digestive and Metabolic Diseases, spoke with EH about today’s emphasis on interdisciplinary exchange and the need to augment cooperation even further. Report: Chrissanthi Nikolakudi
Individualised cancer medication
Among updates on breast cancer diagnostics and treatments aired at the 33rd German Society for Senology meeting last year was SpheroTest, an evidence-based tool that helps select the most effective drug for each individual cancer patient. Report: Anja Behringer
Smart molecular diagnostic tools are on target
Personalised medicine is often equated with the development of drugs tailored to the genetic make-up of patients or cancers.
Personalised Medicine Drives Uptake
Future of DNA sequencing will shift from a laboratory-based setup to point of care testing in the next 5 years
Holmium microspheres for image-guided cancer treatment
Over the next few years, the University Medical Center (UMC) Utrecht and Quirem Medical will be working closely together to maximize the benefits of using holmium microspheres to treat liver cancer patients worldwide.
Liver tumors: 3-D MRI scans better predict survival after chemo
In a series of studies involving 140 American men and women with liver tumors, researchers at Johns Hopkins have used specialized 3-D MRI scans to precisely measure living and dying tumor tissue to quickly show whether highly toxic chemotherapy – delivered directly through a tumor’s blood supply – is working.
The future of radiology: Art or science?
Two things that radiologists resist – structured reporting and (computer-assisted) quantification – are the very things that Gabriel Krestin believes are essential to advance diagnosis in the brave new world of omic-medicine that is emerging.
Article • MEDICA 2013
Genetically targeted medicine forges ahead
Healthcare is undergoing a major change set to offer a real prospect of far more genetically targeted treatments, according a leading human geneticist Sir John Burn, Professor of Clinical Genetics at Newcastle University, England.
